GEORGE GOLUMBESKI

Profile

First Name

: GEORGE

Middle Name

:

Last Name

: GOLUMBESKI

Related Companies

Titles

Company Name

Related People

DIRECTOR

KSQ THERAPEUTICS, INC.

DAVID A. BERRY, M.D., PH.D., ALAN L. CRANE, JAMES GILBERT, DAVID P. MEEKER, M.D., RICHARD A. MOSCICKI, PH.D., FRANK STEGMEIER, PH.D., JOHN TRZUPEK, PH.D.

DIRECTOR

SHATTUCK LABS, INC.

TYLER BROUS, CHARLES DORRANCE, NEIL GIBSON, CHARLES GOLUMBESKI, JOSIAH HORNBLOWER, CHRIS HURFF, MIKE LEE, G. WALTER LOEWENBAUM, WALTER LOEWENBAUM, DAVID G. LOWE, TAYLOR SCHREIBER, VICTOR STONE

DIRECTOR

SAGE THERAPEUTICS, INC.

ELIZABETH BARRETT, MICHAEL CLOONAN, MICHAEL F. COLA, ANNE MARIE COOK, JAMES F. FRATES, GENO GERMANO, BARRY GREENE, KIMI IGUCHI, JEFFERY M. JONAS, JEFFREY M. JONAS, STEPHEN J. KANES, ROBERT T. NELSEN, STEVEN PAUL, ALBERT J. ROBICHAUD, KEVIN STARR, KEVIN P. STARR

DIRECTOR

CHROMA MEDICINE, INC.

KEVIN BITTERMAN, THOMAS CAHILL, BIHUA CHEN, BRETT KAPLAN, MICHAEL KELLY, JEFF MARRAZZO, VIC MYER, PAOLA POZZI, CATHERINE STEHMAN-BREEN

DIRECTOR

KEVIN BITTERMAN, SAM BJORK, OMMER CHOHAN, ROBERT GAFFEY, JAMES JEFFREY GOATER, CHELSEA PLACE JOHNSON, ANKIT MAHADEVIA, HUI TIAN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-07-31

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-02-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-02-08

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2020-12-31

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-06-12

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-01-31

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-09-17

D

BIOTECHNOLOGY

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]

DECLINE TO DISCLOSE

Equity

2013-09-24

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-12-22